← FDA DRUG APPROVALS

FDA NDA · NDA215319

DOLUTEGRAVIR

Sponsor: LAURUS GENERICS INC

APPLICATION
NDA215319
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
FILM
MARKETING STATUS
Prescription

Products

DOLUTEGRAVIRPrescription
DOLUTEGRAVIR 5MG · FILM · ORAL
DOLUTEGRAVIRPrescription
DOLUTEGRAVIR 10MG · FILM · ORAL

Approval history

2023-04-28Type 5 - New Formulation or New Manufacturer · Original · priorityLetterTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →